Cooper Companies (NYSE:COO) Research Coverage Started at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Cooper Companies (NYSE:COO – Get Rating) in a research note issued to investors on Thursday. The firm set a “hold” rating on the medical device company’s stock.

A number of other research analysts also recently issued reports on the company. Mizuho upped their price target on Cooper Companies from $385.00 to $390.00 in a report on Friday, March 3rd. Piper Sandler upped their price target on Cooper Companies from $350.00 to $375.00 and gave the company an “overweight” rating in a report on Wednesday, January 11th. Citigroup upped their price target on Cooper Companies from $348.00 to $368.00 and gave the company a “buy” rating in a report on Monday, December 12th. JPMorgan Chase & Co. upped their price objective on Cooper Companies from $300.00 to $330.00 in a research report on Monday, November 28th. Finally, Robert W. Baird upped their price objective on Cooper Companies from $371.00 to $385.00 in a research report on Friday, March 3rd. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $382.60.

Cooper Companies Trading Down 0.2 %

Cooper Companies stock opened at $338.63 on Thursday. The company has a current ratio of 1.72, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36. The business’s fifty day simple moving average is $342.02 and its two-hundred day simple moving average is $311.53. Cooper Companies has a 12 month low of $244.21 and a 12 month high of $429.89. The company has a market capitalization of $16.75 billion, a price-to-earnings ratio of 44.85, a price-to-earnings-growth ratio of 2.32 and a beta of 0.89.

Cooper Companies (NYSE:COO – Get Rating) last announced its quarterly earnings results on Thursday, March 2nd. The medical device company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.66 by $0.24. The firm had revenue of $858.50 million for the quarter, compared to the consensus estimate of $834.90 million. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The company’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the prior year, the company posted $3.24 earnings per share. As a group, equities analysts predict that Cooper Companies will post 12.74 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Cooper Companies news, COO Gerard H. Warner III sold 1,216 shares of the company’s stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $340.53, for a total value of $414,084.48. Following the completion of the sale, the chief operating officer now owns 1,290 shares in the company, valued at $439,283.70. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, Director Jody S. Lindell sold 1,000 shares of the stock in a transaction dated Friday, January 6th. The stock was sold at an average price of $344.30, for a total transaction of $344,300.00. Following the completion of the sale, the director now owns 13,543 shares in the company, valued at $4,662,854.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Gerard H. Warner III sold 1,216 shares of the stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $340.53, for a total value of $414,084.48. Following the sale, the chief operating officer now owns 1,290 shares of the company’s stock, valued at approximately $439,283.70. The disclosure for this sale can be found here. Insiders sold a total of 39,726 shares of company stock worth $13,426,262 over the last quarter. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Cooper Companies

Several institutional investors have recently made changes to their positions in the business. B. Riley Wealth Advisors Inc. purchased a new stake in shares of Cooper Companies during the fourth quarter worth about $221,000. Voya Investment Management LLC boosted its stake in Cooper Companies by 5.0% during the fourth quarter. Voya Investment Management LLC now owns 220,716 shares of the medical device company’s stock valued at $72,984,000 after buying an additional 10,581 shares during the last quarter. Natixis boosted its stake in Cooper Companies by 107.1% during the fourth quarter. Natixis now owns 6,669 shares of the medical device company’s stock valued at $2,205,000 after buying an additional 3,449 shares during the last quarter. Macquarie Group Ltd. boosted its stake in Cooper Companies by 6.6% during the fourth quarter. Macquarie Group Ltd. now owns 367,509 shares of the medical device company’s stock valued at $121,524,000 after buying an additional 22,665 shares during the last quarter. Finally, Wallace Advisory Group LLC bought a new position in Cooper Companies during the fourth quarter valued at approximately $220,000. Hedge funds and other institutional investors own 96.78% of the company’s stock.

Cooper Companies Company Profile

(Get Rating)

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.